Statutory authority for Medicare coverage decisions - CMS is an independent federal agency

28 July 2023 - It is time for the public to recognize and strongly support the authority of the US Centers ...

Read more →

Changes to CADTH’s rapid response service

20 July 2023 - As CADTH continues along the path of strategic transformation, we’re working hard to align the evidence products ...

Read more →

Chamber of Commerce asks judge to block Medicare drug price negotiations before October

12 July 2023 - The US Chamber of Commerce on Wednesday asked a federal judge in Ohio to block Medicare’s new ...

Read more →

Health Canada approves Lynparza in combination with abiraterone and prednisone or prednisolone for patients with BRCA mutated metastatic castration-resistant prostate cancer

13 July 2023 - Conditional approval based on data from Phase 3 PROpel trial. ...

Read more →

Medicare’s plan for drug-price negotiation - the importance of defining generic entry

8 July 2023 - The Inflation Reduction Act allows CMS to negotiate prices for a small number of Medicare covered ...

Read more →

IRA extends insulin cost caps to Medicare Part B and Medicare Advantage Starting 1 July

30 June 2023 - Starting 1 July, people with Medicare Part B and Medicare Advantage coverage who get their insulin through ...

Read more →

CMS releases revised guidance for historic Medicare drug price negotiation program

30 June 2023 - For the first time in history, Medicare has the ability to directly negotiate the prices of covered ...

Read more →

Medicare offers details on reimbursement for new Alzheimer's drugs

22 June 2023 - The US Medicare health plan on Thursday offered details of plans to collect patient data as ...

Read more →

PhRMA sues Biden administration over Medicare drug price negotiations

21 June 2023 - The pharmaceutical industry’s largest lobbying group on Wednesday filed a lawsuit challenging provisions in the Biden ...

Read more →

Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancer

21 June 2023 - NICE has published final evidence-based recommendations on the use of pembrolizumab (Keytruda) in combination with lenvatinib ...

Read more →

Teikoku Pharma granted FDA fast track designation for TPU-006, a novel 4 day dexmedetomidine transdermal system for post operative pain management

21 June 2023 - Teikoku Pharma today announced that the US FDA granted fast track designation for TPU-006 in managing post-operative ...

Read more →

Dapagliflozin propanediol monohydrate for the treatment of adults with chronic heart failure with preserved or mildly reduced ejection fraction

21 June 2023 - NICE has published final evidence-based recommendations on the use of dapagliflozin propanediol monohydrate for the treatment ...

Read more →

Here's how law makers can slash Medicare spending without cutting benefits

30 May 2023 - Politicians don't agree on much these days, but one thing seems to bring even Democrats and ...

Read more →

CMS announces plan to ensure availability of new Alzheimer’s drugs

1 June 2023 - Agency outlines how people with Medicare can get these drugs if FDA grants traditional approval ...

Read more →

US FDA approves the Cyltezo Pen, a new auto-injector option, ahead of 1 July commercial launch

22 May 2023 - Cyltezo (adalimumab-adbm) will be commercially available in the US beginning on 1 July 2023. ...

Read more →